🔎 Trials Near Me

Home › Stomach Cancer › Connecticut › New Haven

Stomach Cancer clinical trials in New Haven, CT

8 studies for Stomach Cancer are looking for participants at sites in and around New Haven (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

RecruitingPhase 2
  • Yale Cancer Center, New Haven
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06172478

A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

RecruitingPhase 1
  • Yale Cancer Center, New Haven
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07578571

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

RecruitingPhase 1
  • Yale University - Yale University School of Medicine, New Haven
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07360314

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

RecruitingPhase 3
  • Yale Cancer Center, New Haven
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT06731478

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

RecruitingPhase 1
  • Yale New Haven Hospital, New Haven
Ages 18 and older · All sexes · Updated Jun 15, 2026 · NCT05768932

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

RecruitingPhase 1/2
  • Yale University, Yale Cancer Center, New Haven
Ages 18 and older · All sexes · Updated Mar 27, 2026 · NCT06395519

About Stomach Cancer

Did you know risk factors for stomach (gastric) cancer include a diet high in salty or smoked food or having an H. pylori infection? Learn more here.

More about Stomach Cancer on MedlinePlus

Stomach Cancer trials in other cities

Other studies in New Haven

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.